SCHEMBL7218978

SCHEMBL7218978

C/C(=N/COC(=O)c1ccccc1)N(O)CCCC[C@H](N)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC1A5 Q15758 1/20 0.41
NOS2 P35228 5/20 0.39
NOS1 P29475 4/20 0.39
NOS3 P29474 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
BLM P54132 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
SLC7A5 Q01650 2/20 0.37
MEN1 O00255 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7218981 1.00 SLC1A5 (0.41) SLC1A5NOS2NOS1NOS3CYP1A2
SCHEMBL7901280 0.83 NOS2 (0.46) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7901279 0.83 NOS2 (0.46) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7219068 0.81 NOS2 (0.43) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7219063 0.81 NOS2 (0.43) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7909539 0.79 NOS2 (0.42) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7909546 0.79 NOS2 (0.42) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7909642 0.79 NOS2 (0.43) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7909648 0.79 NOS2 (0.43) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7901714 0.78 SLC1A5 (0.41) SLC1A5NOS2NOS1NOS3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US claimed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP claimed
WO-1997032844-A9 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS 1997-12-24 WO claimed
US-6576780-B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors GD SEARLE & COMPANY 2003-06-10 US disclosed
WO-1997032844-A9 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS 1997-12-24 WO disclosed